Table of Content

1 Receptor Tyrosine Protein Kinase ERBB 3 Market Overview
1.1 Product Overview and Scope of Receptor Tyrosine Protein Kinase ERBB 3
1.2 Receptor Tyrosine Protein Kinase ERBB 3 Segment by Type
1.2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Value Comparison by Type (2024-2034)
1.2.2 BA-0702
1.2.3 CDX-3379
1.2.4 Elgemtumab
1.2.5 ETBX-031
1.2.6 Others
1.3 Receptor Tyrosine Protein Kinase ERBB 3 Segment by Application
1.3.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Value by Application: (2024-2034)
1.3.2 Non-Small Cell Carcinoma
1.3.3 Solid Tumor
1.3.4 Melanoma
1.3.5 Colorectal Cancer
1.3.6 Others
1.4 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size Estimates and Forecasts
1.4.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue 2018-2034
1.4.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales 2018-2034
1.4.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Receptor Tyrosine Protein Kinase ERBB 3 Market Competition by Manufacturers
2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Manufacturers (2018-2024)
2.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Average Price by Manufacturers (2018-2024)
2.4 Global Receptor Tyrosine Protein Kinase ERBB 3 Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Receptor Tyrosine Protein Kinase ERBB 3, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Receptor Tyrosine Protein Kinase ERBB 3, Product Type & Application
2.7 Receptor Tyrosine Protein Kinase ERBB 3 Market Competitive Situation and Trends
2.7.1 Receptor Tyrosine Protein Kinase ERBB 3 Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Receptor Tyrosine Protein Kinase ERBB 3 Players Market Share by Revenue
2.7.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Receptor Tyrosine Protein Kinase ERBB 3 Retrospective Market Scenario by Region
3.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region: 2018-2034
3.2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region: 2018-2024
3.2.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region: 2024-2034
3.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Region: 2018-2034
3.3.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Region: 2018-2024
3.3.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Region: 2024-2034
3.4 North America Receptor Tyrosine Protein Kinase ERBB 3 Market Facts & Figures by Country
3.4.1 North America Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2018-2034)
3.4.3 North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Facts & Figures by Country
3.5.1 Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2018-2034)
3.5.3 Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market Facts & Figures by Country
3.6.1 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2018-2034)
3.6.3 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Receptor Tyrosine Protein Kinase ERBB 3 Market Facts & Figures by Country
3.7.1 Latin America Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2018-2034)
3.7.3 Latin America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Facts & Figures by Country
3.8.1 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2018-2034)
3.8.3 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2018-2034)
4.1.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2018-2024)
4.1.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2024-2034)
4.1.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2018-2034)
4.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type (2018-2034)
4.2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type (2018-2024)
4.2.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type (2024-2034)
4.2.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Type (2018-2034)
4.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Price by Type (2018-2034)
5 Segment by Application
5.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2018-2034)
5.1.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2018-2024)
5.1.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2024-2034)
5.1.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2018-2034)
5.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Application (2018-2034)
5.2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Application (2018-2024)
5.2.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Application (2024-2034)
5.2.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Application (2018-2034)
5.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Price by Application (2018-2034)
6 Key Companies Profiled
6.1 AstraZeneca Plc
6.1.1 AstraZeneca Plc Corporation Information
6.1.2 AstraZeneca Plc Description and Business Overview
6.1.3 AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2018-2024)
6.1.4 AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
6.1.5 AstraZeneca Plc Recent Developments/Updates
6.2 AVEO Pharmaceuticals, Inc.
6.2.1 AVEO Pharmaceuticals, Inc. Corporation Information
6.2.2 AVEO Pharmaceuticals, Inc. Description and Business Overview
6.2.3 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2018-2024)
6.2.4 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
6.2.5 AVEO Pharmaceuticals, Inc. Recent Developments/Updates
6.3 Etubics Corporation
6.3.1 Etubics Corporation Corporation Information
6.3.2 Etubics Corporation Description and Business Overview
6.3.3 Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
6.3.5 Etubics Corporation Recent Developments/Updates
6.4 F. Hoffmann-La Roche Ltd.
6.4.1 F. Hoffmann-La Roche Ltd. Corporation Information
6.4.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.4.3 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2018-2024)
6.4.4 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
6.4.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.5 GamaMabs Pharma S.A.
6.5.1 GamaMabs Pharma S.A. Corporation Information
6.5.2 GamaMabs Pharma S.A. Description and Business Overview
6.5.3 GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2018-2024)
6.5.4 GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
6.5.5 GamaMabs Pharma S.A. Recent Developments/Updates
6.6 GlaxoSmithKline Plc
6.6.1 GlaxoSmithKline Plc Corporation Information
6.6.2 GlaxoSmithKline Plc Description and Business Overview
6.6.3 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2018-2024)
6.6.4 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
6.6.5 GlaxoSmithKline Plc Recent Developments/Updates
6.7 Hanmi Pharmaceuticals, Co. Ltd.
6.6.1 Hanmi Pharmaceuticals, Co. Ltd. Corporation Information
6.6.2 Hanmi Pharmaceuticals, Co. Ltd. Description and Business Overview
6.6.3 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
6.7.5 Hanmi Pharmaceuticals, Co. Ltd. Recent Developments/Updates
6.8 ImmunoGen, Inc.
6.8.1 ImmunoGen, Inc. Corporation Information
6.8.2 ImmunoGen, Inc. Description and Business Overview
6.8.3 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2018-2024)
6.8.4 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
6.8.5 ImmunoGen, Inc. Recent Developments/Updates
6.9 Kolltan Pharmaceuticals, Inc.
6.9.1 Kolltan Pharmaceuticals, Inc. Corporation Information
6.9.2 Kolltan Pharmaceuticals, Inc. Description and Business Overview
6.9.3 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
6.9.5 Kolltan Pharmaceuticals, Inc. Recent Developments/Updates
6.10 Merrimack Pharmaceuticals, Inc.
6.10.1 Merrimack Pharmaceuticals, Inc. Corporation Information
6.10.2 Merrimack Pharmaceuticals, Inc. Description and Business Overview
6.10.3 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
6.10.5 Merrimack Pharmaceuticals, Inc. Recent Developments/Updates
6.11 Merus B.V.
6.11.1 Merus B.V. Corporation Information
6.11.2 Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Description and Business Overview
6.11.3 Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
6.11.5 Merus B.V. Recent Developments/Updates
6.12 Novartis AG
6.12.1 Novartis AG Corporation Information
6.12.2 Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Description and Business Overview
6.12.3 Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
6.12.5 Novartis AG Recent Developments/Updates
6.13 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
6.13.1 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Corporation Information
6.13.2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Description and Business Overview
6.13.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
6.13.5 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
6.14 Sihuan Pharmaceutical Holdings Group Ltd.
6.14.1 Sihuan Pharmaceutical Holdings Group Ltd. Corporation Information
6.14.2 Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Description and Business Overview
6.14.3 Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
6.14.5 Sihuan Pharmaceutical Holdings Group Ltd. Recent Developments/Updates
6.15 Sorrento Therapeutics, Inc.
6.15.1 Sorrento Therapeutics, Inc. Corporation Information
6.15.2 Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Description and Business Overview
6.15.3 Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
6.15.5 Sorrento Therapeutics, Inc. Recent Developments/Updates
6.16 Symphogen A/S
6.16.1 Symphogen A/S Corporation Information
6.16.2 Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Description and Business Overview
6.16.3 Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
6.16.5 Symphogen A/S Recent Developments/Updates
6.17 Takis S.r.l.
6.17.1 Takis S.r.l. Corporation Information
6.17.2 Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Description and Business Overview
6.17.3 Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
6.17.5 Takis S.r.l. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Receptor Tyrosine Protein Kinase ERBB 3 Industry Chain Analysis
7.2 Receptor Tyrosine Protein Kinase ERBB 3 Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Receptor Tyrosine Protein Kinase ERBB 3 Production Mode & Process
7.4 Receptor Tyrosine Protein Kinase ERBB 3 Sales and Marketing
7.4.1 Receptor Tyrosine Protein Kinase ERBB 3 Sales Channels
7.4.2 Receptor Tyrosine Protein Kinase ERBB 3 Distributors
7.5 Receptor Tyrosine Protein Kinase ERBB 3 Customers
8 Receptor Tyrosine Protein Kinase ERBB 3 Market Dynamics
8.1 Receptor Tyrosine Protein Kinase ERBB 3 Industry Trends
8.2 Receptor Tyrosine Protein Kinase ERBB 3 Market Drivers
8.3 Receptor Tyrosine Protein Kinase ERBB 3 Market Challenges
8.4 Receptor Tyrosine Protein Kinase ERBB 3 Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Competitive Situation by Manufacturers in 2022
Table 4. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) of Key Manufacturers (2018-2024)
Table 5. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Receptor Tyrosine Protein Kinase ERBB 3 Average Price (USD/Pcs) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Receptor Tyrosine Protein Kinase ERBB 3, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Receptor Tyrosine Protein Kinase ERBB 3, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Receptor Tyrosine Protein Kinase ERBB 3, Product Type & Application
Table 12. Global Key Manufacturers of Receptor Tyrosine Protein Kinase ERBB 3, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Receptor Tyrosine Protein Kinase ERBB 3 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Receptor Tyrosine Protein Kinase ERBB 3 as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region (2018-2024) & (K Pcs)
Table 18. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Region (2018-2024)
Table 19. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region (2024-2034) & (K Pcs)
Table 20. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Region (2024-2034)
Table 21. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Region (2018-2024)
Table 23. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Region (2024-2034)
Table 25. North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2018-2024) & (K Pcs)
Table 27. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2024-2034) & (K Pcs)
Table 28. North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2018-2024) & (K Pcs)
Table 32. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2024-2034) & (K Pcs)
Table 33. Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region (2018-2024) & (K Pcs)
Table 37. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region (2024-2034) & (K Pcs)
Table 38. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2018-2024) & (K Pcs)
Table 42. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2024-2034) & (K Pcs)
Table 43. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2018-2024) & (K Pcs)
Table 47. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2024-2034) & (K Pcs)
Table 48. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Type (2018-2024)
Table 51. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Type (2024-2034)
Table 52. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2018-2024)
Table 53. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2024-2034)
Table 54. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Type (2018-2024)
Table 57. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Type (2024-2034)
Table 58. Global Receptor Tyrosine Protein Kinase ERBB 3 Price (USD/Pcs) by Type (2018-2024)
Table 59. Global Receptor Tyrosine Protein Kinase ERBB 3 Price (USD/Pcs) by Type (2024-2034)
Table 60. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Application (2018-2024)
Table 61. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Application (2024-2034)
Table 62. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2018-2024)
Table 63. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2024-2034)
Table 64. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Application (2018-2024)
Table 67. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Application (2024-2034)
Table 68. Global Receptor Tyrosine Protein Kinase ERBB 3 Price (USD/Pcs) by Application (2018-2024)
Table 69. Global Receptor Tyrosine Protein Kinase ERBB 3 Price (USD/Pcs) by Application (2024-2034)
Table 70. AstraZeneca Plc Corporation Information
Table 71. AstraZeneca Plc Description and Business Overview
Table 72. AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 73. AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 74. AstraZeneca Plc Recent Developments/Updates
Table 75. AVEO Pharmaceuticals, Inc. Corporation Information
Table 76. AVEO Pharmaceuticals, Inc. Description and Business Overview
Table 77. AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 78. AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 79. AVEO Pharmaceuticals, Inc. Recent Developments/Updates
Table 80. Etubics Corporation Corporation Information
Table 81. Etubics Corporation Description and Business Overview
Table 82. Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 83. Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 84. Etubics Corporation Recent Developments/Updates
Table 85. F. Hoffmann-La Roche Ltd. Corporation Information
Table 86. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 87. F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 88. F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 89. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 90. GamaMabs Pharma S.A. Corporation Information
Table 91. GamaMabs Pharma S.A. Description and Business Overview
Table 92. GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 93. GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 94. GamaMabs Pharma S.A. Recent Developments/Updates
Table 95. GlaxoSmithKline Plc Corporation Information
Table 96. GlaxoSmithKline Plc Description and Business Overview
Table 97. GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 98. GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 99. GlaxoSmithKline Plc Recent Developments/Updates
Table 100. Hanmi Pharmaceuticals, Co. Ltd. Corporation Information
Table 101. Hanmi Pharmaceuticals, Co. Ltd. Description and Business Overview
Table 102. Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 103. Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 104. Hanmi Pharmaceuticals, Co. Ltd. Recent Developments/Updates
Table 105. ImmunoGen, Inc. Corporation Information
Table 106. ImmunoGen, Inc. Description and Business Overview
Table 107. ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 108. ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 109. ImmunoGen, Inc. Recent Developments/Updates
Table 110. Kolltan Pharmaceuticals, Inc. Corporation Information
Table 111. Kolltan Pharmaceuticals, Inc. Description and Business Overview
Table 112. Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 114. Kolltan Pharmaceuticals, Inc. Recent Developments/Updates
Table 115. Merrimack Pharmaceuticals, Inc. Corporation Information
Table 116. Merrimack Pharmaceuticals, Inc. Description and Business Overview
Table 117. Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 119. Merrimack Pharmaceuticals, Inc. Recent Developments/Updates
Table 120. Merus B.V. Corporation Information
Table 121. Merus B.V. Description and Business Overview
Table 122. Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 124. Merus B.V. Recent Developments/Updates
Table 125. Novartis AG Corporation Information
Table 126. Novartis AG Description and Business Overview
Table 127. Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 129. Novartis AG Recent Developments/Updates
Table 130. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Corporation Information
Table 131. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Description and Business Overview
Table 132. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 133. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 134. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
Table 135. Sihuan Pharmaceutical Holdings Group Ltd. Corporation Information
Table 136. Sihuan Pharmaceutical Holdings Group Ltd. Description and Business Overview
Table 137. Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 138. Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 139. Sihuan Pharmaceutical Holdings Group Ltd. Recent Developments/Updates
Table 140. Sorrento Therapeutics, Inc. Corporation Information
Table 141. Sorrento Therapeutics, Inc. Description and Business Overview
Table 142. Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 143. Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 144. Sorrento Therapeutics, Inc. Recent Developments/Updates
Table 145. Symphogen A/S Corporation Information
Table 146. Symphogen A/S Description and Business Overview
Table 147. Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 148. Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 149. Symphogen A/S Recent Developments/Updates
Table 150. Takis S.r.l. Corporation Information
Table 151. Takis S.r.l. Description and Business Overview
Table 152. Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 153. Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Product
Table 154. Takis S.r.l. Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Receptor Tyrosine Protein Kinase ERBB 3 Distributors List
Table 158. Receptor Tyrosine Protein Kinase ERBB 3 Customers List
Table 159. Receptor Tyrosine Protein Kinase ERBB 3 Market Trends
Table 160. Receptor Tyrosine Protein Kinase ERBB 3 Market Drivers
Table 161. Receptor Tyrosine Protein Kinase ERBB 3 Market Challenges
Table 162. Receptor Tyrosine Protein Kinase ERBB 3 Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Receptor Tyrosine Protein Kinase ERBB 3
Figure 2. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Type in 2022 & 2034
Figure 4. BA-0702 Product Picture
Figure 5. CDX-3379 Product Picture
Figure 6. Elgemtumab Product Picture
Figure 7. ETBX-031 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Application in 2022 & 2034
Figure 11. Non-Small Cell Carcinoma
Figure 12. Solid Tumor
Figure 13. Melanoma
Figure 14. Colorectal Cancer
Figure 15. Others
Figure 16. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 17. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size (2018-2034) & (US$ Million)
Figure 18. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (2018-2034) & (K Pcs)
Figure 19. Global Receptor Tyrosine Protein Kinase ERBB 3 Average Price (USD/Pcs) & (2018-2034)
Figure 20. Receptor Tyrosine Protein Kinase ERBB 3 Report Years Considered
Figure 21. Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Manufacturers in 2022
Figure 22. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Manufacturers in 2022
Figure 23. The Global 5 and 10 Largest Receptor Tyrosine Protein Kinase ERBB 3 Players: Market Share by Revenue in 2022
Figure 24. Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 25. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 26. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Country (2018-2034)
Figure 27. North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Country (2018-2034)
Figure 28. U.S. Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. Canada Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Country (2018-2034)
Figure 31. Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Country (2018-2034)
Figure 32. Germany Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. France Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. U.K. Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Italy Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Russia Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Region (2018-2034)
Figure 38. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Region (2018-2034)
Figure 39. China Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Japan Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. South Korea Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. India Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Australia Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Taiwan Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Indonesia Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Thailand Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Malaysia Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Philippines Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Country (2018-2034)
Figure 50. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Country (2018-2034)
Figure 51. Mexico Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Brazil Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Argentina Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Country (2018-2034)
Figure 55. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Country (2018-2034)
Figure 56. Turkey Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 57. Saudi Arabia Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 58. U.A.E Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 59. Global Sales Market Share of Receptor Tyrosine Protein Kinase ERBB 3 by Type (2018-2034)
Figure 60. Global Revenue Market Share of Receptor Tyrosine Protein Kinase ERBB 3 by Type (2018-2034)
Figure 61. Global Receptor Tyrosine Protein Kinase ERBB 3 Price (USD/Pcs) by Type (2018-2034)
Figure 62. Global Sales Market Share of Receptor Tyrosine Protein Kinase ERBB 3 by Application (2018-2034)
Figure 63. Global Revenue Market Share of Receptor Tyrosine Protein Kinase ERBB 3 by Application (2018-2034)
Figure 64. Global Receptor Tyrosine Protein Kinase ERBB 3 Price (USD/Pcs) by Application (2018-2034)
Figure 65. Receptor Tyrosine Protein Kinase ERBB 3 Value Chain
Figure 66. Receptor Tyrosine Protein Kinase ERBB 3 Production Process
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Distributors Profiles
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed